Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center.

Kiraly P. et al, (2023), Biomolecules, 13

Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy.

Park J. et al, (2023), Genet Med

The Role of Inflammation in Age-Related Macular Degeneration-Therapeutic Landscapes in Geographic Atrophy.

Borchert GA. et al, (2023), Cells, 12

Combined central serous chorioretinopathy, hypermetropia, short axial length, chorioretinal folds, enlarged/thickened ocular coats, with varying association of scleral changes (CHAFES).

Downes SM. et al, (2023), BMC Ophthalmol, 23

Retinal Angiomatous Proliferation in a Patient with Retinitis Pigmentosa.

Kiraly P. et al, (2023), Genes (Basel), 14

New Imaging Technology for Simultaneous Multiwavelength-UWF Fundus Fluorescein Angiography and Indocyanine Green Angiography With Navigated Central and Peripheral SS-OCT

Bravo FJV. et al, (2023), Ophthalmic surgery, lasers & imaging retina, 54, 401 - 410

A Carrier Female Manifesting an Unusual X-Linked Retinoschisis Phenotype Associated with the Pathogenic Variant c.266delA, p.(Tyr89LeufsTer37) in RS1, and Skewed X-Inactivation

Kirkby J. et al, (2023), Genes, 14, 1193 - 1193

Can artificial intelligence accelerate the diagnosis of inherited retinal diseases? Protocol for a data-only retrospective cohort study (Eye2Gene).

Nguyen Q. et al, (2023), BMJ Open, 13

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Feenstra HMA. et al, (2023), Retina, 43, 379 - 388

Intraretinal Microvascular Abnormalities and Venous Beading Have Different Genetic Profiles in Caucasian Patients with Non-Proliferative Diabetic Retinopathy

Pearce E. et al, (2023), Vision (Switzerland), 7

Faricimab in neovascular AMD: first report of real-world outcomes in an independent retina clinic

Stanga PE. et al, (2023), Eye (Basingstoke)

Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel Biomarkers.

Thomas-Black G. et al, (2022), Mov Disord

The inner junction protein CFAP20 functions in motile and non-motile cilia and is critical for vision.

Chrystal PW. et al, (2022), Nat Commun, 13

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom

YUSUF I. et al, (2022), Eye

Phenotypic and Genetic Characteristics in a Cohort of Patients with Usher Genes

Feenstra HM. et al, (2022), Genes, 13, 1423 - 1423

An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma.

Ghanchi F. et al, (2022), Eye (Lond), 36, 1154 - 1167

EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Feenstra HMA. et al, (2022), Retina, 42, 721 - 729

Long term retinal morphology and functional associations in treated neovascular age-related macular degeneration: findings from the IVAN trial.

Peto T. et al, (2022), Ophthalmol Retina

The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.

Hahn LC. et al, (2022), Ophthalmol Retina

Late-Onset Autosomal Dominant Macular Degeneration Caused by Deletion of the CRX Gene

Yahya S. et al, (2022), Ophthalmology

Load More

1
2
3
4
5
6
7
...
»